Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults

DiazGranados, Carlos A., Dunning, Andrew J., Kimmel, Murray, Kirby, Daniel, Treanor, John, Collins, Avi, Pollak, Richard, Christoff, Janet, Earl, John, Landolfi, Victoria, Martin, Earl, Gurunathan, Sanjay, Nathan, Richard, Greenberg, David P., Tornieporth, Nadia G., Decker, Michael D., Talbot, H. Keipp·2014·New England Journal of Medicine

DOI 10.1056/nejmoa1315727

Cited by (878)

Items 101–200 of 878

Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination
Rodrigo B. Abreu, Greg A. Kirchenbaum, Emily F. Clutter, Giuseppe Andrea Sautto, Ted M. Ross · 2019 · JCI Insight
Roadmap to 2030 for Drug Evaluation in Older Adults
Qi Liu, Janice B. Schwartz, Patricia W. Slattum, S.W. Johnny Lau, Daphne Guinn, Rajanikanth Madabushi, Gilbert J. Burckart, Robert M. Califf, Francesca Cerreta, Carolyn Cho et al. · 2021 · Clinical Pharmacology & Therapeutics
High-dose influenza vaccine in older adults by age and seasonal characteristics: Systematic review and meta-analysis update
Jason K. H. Lee, Gary Lam, Jiehui Kevin Yin, Matthew M. Loiacono, Sandrine Samson · 2023 · Vaccine X
Influenza vaccine effectiveness in older adults compared with younger adults over five seasons
Kate E.R. Russell, Jessie R. Chung, Arnold S. Monto, Emily Toth Martin, Edward A. Belongia, Huong Q. McLean, Manjusha Gaglani, Kempapura Murthy, Richard Kent Zimmerman, Mary Patricia Nowalk et al. · 2018 · Vaccine
Influenza vaccination in patients with heart failure: a systematic review and meta-analysis of observational studies
Bárbara Katherine Ataide Barros Rodrigues, Cláudio David, João N. Costa, Joaquim José Ferreira, Fausto José Pinto, Daniel Caldeira · 2019 · Heart
A Pragmatic Randomized Feasibility Trial of Influenza Vaccines
Niklas Dyrby Johansen, Daniel Modin, Joshua Nealon, Sandrine Samson, Camille Salamand, Matthew M. Loiacono, Carsten Schade Larsen, Anne Marie Reimer Jensen, Nino Emanuel Landler, Brian Lee Claggett et al. · 2023 · NEJM Evidence
Relative Vaccine Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among Veterans Health Administration Patients
Yinong Young‐Xu, Robertus van Aalst, Salaheddin M. Mahmud, Kenneth Jay Rothman, Julia Thornton Snider, Daniel J. Westreich, Vincent Mor, Stefan Gravenstein, Jason K. H. Lee, Edward Wolfgang Thommes et al. · 2018 · The Journal of Infectious Diseases
Challenges in estimating influenza vaccine effectiveness
Kylie E. C. Ainslie, Michael Haber, Walt Orenstein · 2019 · Expert Review of Vaccines
Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients
Natasha Halasa, Bipin N. Savani, Ishan Asokan, Adetola A. Kassim, Rhea Micci Simons, Chelsey Summers, John Bourgeois, Carey Clifton, Leigh Ann Vaughan, Catherine Lucid et al. · 2015 · Transplantation and Cellular Therapy
Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid)
Susanna Esposito, Paolo Bonanni, Stefania Maggi, Litjan Tan, Filippo Ansaldi, Pier Luigi Lopalco, Ron Dagan, Jean‐Pierre Michel, Pierre Van Damme, Jacques Gaillat et al. · 2016 · Human Vaccines & Immunotherapeutics
The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virus
Susanne Simon, Oana Joean, Tobias Welte, Jessica Rademacher · 2023 · European Respiratory Review
Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22–23 March 2017
M. Teresa Aguado, Jane Barratt, John Beard, Bonnie B. Blomberg, Wilbur H. Chen, Julian Hickling, Terri B. Hyde, Mark Jit, Rebecca Jones, Gregory A. Poland et al. · 2018 · Vaccine
Does Influenza Vaccination Modify Influenza Severity? Data on Older Adults Hospitalized With Influenza During the 2012−2013 Season in the United States
Carmen Sofia Arriola, Evan J. Anderson, Jan Baumbach, Nancy M. Bennett, Susan R. Bohm, Mary B. Hill, Mary Lou Lindegren, Krista L. Lung, James I. Meek, Elizabeth Mermel et al. · 2015 · The Journal of Infectious Diseases
Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccination in Community-Dwelling Veterans
Diane M. Richardson, Elina L. Medvedeva, Christopher Brent Roberts, Darren R. Linkin · 2015 · Clinical Infectious Diseases
Greater activation of peripheral T follicular helper cells following high dose influenza vaccine in older adults forecasts seroconversion
Mark A. Pilkinton, Katherine J. Nicholas, Christian M. Warren, Rita M. Smith, Sandra M. Yoder, H. Keipp Talbot, Spyros A. Kalams · 2016 · Vaccine
Vaccines for older adults
Anthony Lawrence Cunningham, Peter Bruce McIntyre, Kanta Subbarao, Robert Booy, Myron J. Levin · 2021 · BMJ
Age-related changes in the immune system and challenges for the development of age-specific vaccines
Mark T. Doherty, Birgit Weinberger, Arnaud M. Didierlaurent, Paul‐Henri Lambert · 2025 · Annals of Medicine
High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults
Niklas Dyrby Johansen, Daniel Modin, Matthew M. Loiacono, Rebecca Claire Harris, Marine Dufournet, Carsten Schade Larsen, Lykke Larsen, Lothar Wiese, Michael Dalager‐Pedersen, Brian Lee Claggett et al. · 2025 · New England Journal of Medicine
Influenza infection and heart failure—vaccination may change heart failure prognosis?
Nikolaos P. E. Kadoglou, Frank A.L.E. Bracke, Tim Simmers, Sotirios Tsiodras, John Parissis · 2017 · Heart Failure Reviews
Travellers and influenza: risks and prevention
Marco Goeijenbier, Perry J.J. van Genderen, Brian J. Ward, Annelies Wilder‐Smith, Robert J. Steffen, Albert D. M. E. Osterhaus · 2016 · Journal of Travel Medicine
Nosocomial influenza: encouraging insights and future challenges
Philippe Vanhems, Thomas Bénet, E. Munier-Marion · 2016 · Current Opinion in Infectious Diseases
Projected Population Benefit of Increased Effectiveness and Coverage of Influenza Vaccination on Influenza Burden in the United States
Michelle M. Hughes, Carrie Reed, Brendan L. Flannery, Shikha Garg, James A. Singleton, Alicia M. Fry, Melissa A R Rolfes · 2019 · Clinical Infectious Diseases
Vaccines and Disease-Modifying Antirheumatic Drugs
Marcia Friedman, Kevin L. Winthrop · 2016 · Rheumatic Disease Clinics of North America
Community-Acquired Pneumonia
Michael S. Niederman · 2015 · Annals of Internal Medicine
Can Vaccinations Improve Heart Failure Outcomes?
Ankeet S. Bhatt, Adam D. DeVore, Adrian F. Hernandez, Robert John Mentz · 2017 · JACC Heart Failure
Impact of aging and HIV infection on serologic response to seasonal influenza vaccination
Suresh Pallikkuth, Lesley R. de Armas, Rajendra Pahwa, Stefano Rinaldi, Varghese K. George, Celeste M. Sanchez, Li Pan, Gordon M. Dickinson, Allan E. Rodriguez, Margaret A. Fischl et al. · 2018 · AIDS
Saikosaponin A inhibits influenza A virus replication and lung immunopathology
Jianxin Chen, Mubing Duan, Yaqin Zhao, Fangfang Ling, Kun Xiao, Qian Li, Bin Li, Chunni Lu, Wenbao Qi, Zhenling Zeng et al. · 2015 · Oncotarget
The establishment of surrogates and correlates of protection: Useful tools for the licensure of effective influenza vaccines?
Brian J. Ward, Stéphane Pillet, Nathalie Charland, Sonia Trépanier, Julie Couillard, Nathalie Landry · 2017 · Human Vaccines & Immunotherapeutics
Patients and investigators prefer measures of absolute risk in subgroups for pragmatic randomized trials
Eleanor J. Murray, Ellen C. Caniglia, Sonja Alsemgeest Swanson, Sonia Hernández–Dı́az, Miguel Ángel Hernán · 2018 · Journal of Clinical Epidemiology
Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors
Ayman Chit, Julie Roïz, B. Briquet, David P. Greenberg · 2014 · Vaccine
A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control
Riju Ray, Gaël Dos Santos, Philip O. Buck, Carine Claeys, Gonçalo Matias, Bruce L. Innis, Rafik Bekkat-Berkani · 2017 · Human Vaccines & Immunotherapeutics
Comparative effectiveness of high dose versus adjuvanted influenza vaccine: A retrospective cohort study
Robertus van Aalst, Stefan Gravenstein, Vincent Mor, Salaheddin M. Mahmud, Jan Wilschut, Maarten Jacobus Postma, Ayman Chit · 2019 · Vaccine
Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change
Tamàs Fülöp, Anis Larbi, Graham Pawelec, Alan Arthur Cohen, Guillaume Provost, Abdelouahed Khalil, Guy Lacombe, Serafim Rodrigues, Mathieu Desroches, Katsuiku Hirokawa et al. · 2022 · Vaccines
Fluzone® High-Dose Influenza Vaccine
Corwin A. Robertson, Carlos A. DiazGranados, Michael D. Decker, Ayman Chit, Monica Mercer, David P. Greenberg · 2016 · Expert Review of Vaccines
Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review
Ettore Crimi, Giuditta Benincasa, Neisaliz Figueroa-Marrero, Massimiliano Galdiero, Claudio Napoli A · 2020 · British Journal of Anaesthesia
Aging and Options to Halt Declining Immunity to Virus Infections
Miguel Ángel Palacios-Pedrero, Albert D. M. E. Osterhaus, Tanja Becker, Husni Elbahesh, Guus F. Rimmelzwaan, Giulietta Saletti · 2021 · Frontiers in Immunology
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study
Joseph E. Ebinger, Gregory J. Botwin, Christine M. Albert, Mona Alotaibi, Moshe Arditi, Anders Hayden Berg, Aleksandra Binek, Patrick G. Botting, Justyna Fert‐Bober, Jane C. Figueiredo et al. · 2021 · BMJ Open
Influenza in Older Adults
H. Keipp Talbot · 2017 · Infectious Disease Clinics of North America
Optimizing the impact of low-efficacy influenza vaccines
Pratha Sah, Jan Medlock, Meagan C. Fitzpatrick, Burton H. Singer, Alison P. Galvani · 2018 · Proceedings of the National Academy of Sciences
miR-181a-regulated pathways in T-cell differentiation and aging
Chulwoo Kim, Zhongde Ye, Cornelia M. Weyand, Jörg J. Goronzy · 2021 · Immunity & Ageing
Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD): an individual-level pooled analysis
Niklas Dyrby Johansen, Daniel Modin, Jacobo Pardo‐Seco, Carmen Rodrı́guez-Tenreiro, Matthew M. Loiacono, Rebecca Claire Harris, Marine Dufournet, Robertus van Aalst, Ayman Chit, Carsten Schade Larsen et al. · 2025 · The Lancet
Influenza in temperate and tropical Asia: a review of epidemiology and vaccinology
Barnaby Edward Young, Mark I-Cheng Chen · 2020 · Human Vaccines & Immunotherapeutics
Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection
Hana Hakim, Kim Allison, Lee-Ann Van de Velde, Li Tang, Yilun Sun, Patricia M. Flynn, Jonathan A. McCullers · 2016 · Vaccine
Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial
Matteo Mombelli, Nils Rettby, Matthieu Perreau, Manuel A. Pascual, Giuseppe Pantaleo, Oriol Manuel · 2018 · Vaccine
B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat
Jenna J. Guthmiller, Henry A. Utset, Patrick C. Wilson · 2021 · Viruses
Development and applications of single-cycle infectious influenza A virus (sciIAV)
Aitor Nogales, Steven F. Baker, William Domm, Luis Martínez‐Sobrido · 2015 · Virus Research
Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial
Ole Fröbert, Matthias Götberg, Oskar Angerås, Lena Jonasson, David Erlinge, Thomas Engstrøm, Jonas Persson, Svend Eggert Jensen, Elmir Ömerovic, Stefan Karl James et al. · 2017 · American Heart Journal
In Silico Vaccine Strain Prediction for Human Influenza Viruses
Thorsten R. Klingen, Susanne Reimering, Carlos A. Guzmán, Alice Carolyn McHardy · 2017 · Trends in Microbiology
Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017–2018 and 2018–2019 Influenza Seasons
Constantina Boikos, Lauren Fischer, Dan O’Brien, Joe Vasey, Gregg C. Sylvester, James A. Mansi · 2021 · Clinical Infectious Diseases
High-Dose Influenza Vaccine to Reduce Hospitalizations
Jacobo Pardo‐Seco, Carmen Rodrı́guez-Tenreiro, Iago Giné-Vázquez, Narmeen Mallah, Susana Mirás‐Carballal, Marta Piñeiro-Sotelo, Martín Cribeiro-González, Mónica Conde-Pájaro, Juan‐Manuel González‐Pérez, Irene Rivero Calle et al. · 2025 · New England Journal of Medicine
The life cycle of a T cell after vaccination – where does immune ageing strike?
Chulwoo Kim, Fengqin Fang, Cornelia M. Weyand, Jörg J. Goronzy · 2016 · Clinical & Experimental Immunology
Comprehensive analysis of antibody recognition in convalescent humans from highly pathogenic avian influenza H5N1 infection
Teng Zuo, Jianfeng Sun, Guiqin Wang, Liwei Jiang, Yanan Zuo, Danyang Li, Xuanling Shi, Xi Liu, Shilong Fan, Huanhuan Ren et al. · 2015 · Nature Communications
Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine
Vivek Shinde, Louis F Fries, Yukun Wu, Sapeckshita Agrawal, Iksung Cho, D. Nigel Thomas, Michelle S Spindler, Elizabeth Lindner, Timothy J. Hahn, Joyce S. Plested et al. · 2018 · New England Journal of Medicine
Randomized, Controlled Trial of High-Dose Influenza Vaccine Among Frail Residents of Long-Term Care Facilities
David A. Nace, Chyongchiou Jeng Lin, Ted M. Ross, Stacey Saracco, Roberta M. Churilla, Richard Kent Zimmerman · 2014 · The Journal of Infectious Diseases
Vaccination of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient
Mini Kamboj, Monika K. Shah · 2019 · Infectious Disease Clinics of North America
Influenza vaccination for elderly, vulnerable and high-risk subjects: a narrative review and expert opinion
Raffaele Antonelli Incalzi, Agostino Consoli, Pierluigi Lopalco, Stefania Maggi, Giorgio Sesti, Nicola Veronese, Massimo Volpe · 2023 · Internal and Emergency Medicine
Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part II
Nancy F. Crum‐Cianflone, Eva L. Sullivan · 2017 · Infectious Diseases and Therapy
An extra priming dose of hepatitis A vaccine to adult patients with rheumatoid arthritis and drug induced immunosuppression – A prospective, open-label, multi-center study
Anja Rosdahl, Christian Herzog, Gert Frösner, Torbjörn Norén, Lars Rombo, Helena Hervius Askling · 2017 · Travel Medicine and Infectious Disease
Single dose combination nanovaccine provides protection against influenza A virus in young and aged mice
Kathleen A. Ross, Sujata Senapati, Jessica Alley, Ross J. Darling, Jonathan Goodman, Matthew A. Jefferson, Metin Uz, Baoqing Guo, Kyoungjin J. Yoon, David E. Verhoeven et al. · 2019 · Biomaterials Science
Influenza Vaccination: Effectiveness, Indications, and Limits in the Pediatric Population
Chiara Mameli, Ilaria Cocchi, Mara Fumagalli, Gianvincenzo Zuccotti · 2019 · Frontiers in Pediatrics
Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study
Jiřı́ Beran, Humberto Reynales, Airi Põder, Charles Y. Yu, Punnee Pitisuttithum, Lee Li Yuan, Wim Vermeulen, Carole Verhoeven, Brett A. Leav, Bin Zhang et al. · 2021 · The Lancet Infectious Diseases
The metabolic hormone leptin promotes the function of TFH cells and supports vaccine responses
Jun Deng, Qian Chen, Zhian Chen, Kaili Liang, Xin Gao, Xiaohui Wang, Fadzai Victor Makota, Hong Sheng Ong, Yanmin Wan, Kaiming Luo et al. · 2021 · Nature Communications
Systematic review of the efficacy, effectiveness and safety of high‐dose seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in individuals ≥18 years of age
Laura Comber, Éamon Ó Murchú, Karen Jordan, Sarah Hawkshaw, Liam Marshall, Michelle O’Neill, Conor Teljeur, Máirín Ryan, AnnaSara Carnahan, Jaime Jesús Pérez Martín et al. · 2022 · Reviews in Medical Virology
Challenges in the Vaccination of the Elderly and Strategies for Improvement
Gatot Soegiarto, Dewajani Purnomosari · 2023 · Pathophysiology
Cost-effectiveness of routine annual influenza vaccination by age and risk status
Ellen Kim DeLuca, Acham Gebremariam, Angela Rose, Matthew Biggerstaff, Martin I. Meltzer, Lisa A. Prosser · 2023 · Vaccine
Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial
Ayman Chit, Debbie L. Becker, Carlos A. DiazGranados, Michael Maschio, Eddy Yau, Michael Drummond · 2015 · The Lancet Infectious Diseases
A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly
Yotam Levin, Efrat Kochba, Georgi Shukarev, Sarah Rusch, Guillermo Herrera‐Taracena, Pierre Van Damme · 2016 · Vaccine
High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial
Orly Vardeny, Jacob Allen Udell, Jacob Joseph, Michael E. Farkouh, Adrian F. Hernandez, Allison McGeer, H. Keipp Talbot, Deepak L. Bhatt, Christopher Paul Cannon, Shaun G. Goodman et al. · 2018 · American Heart Journal
Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine
Luis Martínez‐Sobrido, Olve B. Peersen, Aitor Nogales · 2018 · Viruses
Beneficial Effects of Vaccination on Cardiovascular Events: Myocardial Infarction, Stroke, Heart Failure
Katerina Fountoulaki, Sotirios Tsiodras, Effie Polyzogopoulou, C. D. Olympios, John Parissis · 2018 · Cardiology
Impact of age and pre-existing immunity on the induction of human antibody responses against influenza B viruses
Michael A. Carlock, John G. Ingram, Emily F. Clutter, Noah C. Cecil, Moti N. Ramgopal, Richard Kent Zimmerman, William Warren, Harry Kleanthous, Ted M. Ross · 2019 · Human Vaccines & Immunotherapeutics
Impaired HA-specific T follicular helper cell and antibody responses to influenza vaccination are linked to inflammation in humans
Danika Lea Hill, Carly E. Whyte, Silvia Innocentin, Jia Le Lee, James Dooley, Jiong Wang, Eddie A. James, James Christopher Lee, William W Kwok, Martin Stuart Zand et al. · 2021 · eLife
Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I
Nancy F. Crum‐Cianflone, Eva L. Sullivan · 2017 · Infectious Diseases and Therapy
Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis
Sandrine Samson, Phillip S. Leventhal, Camille Salamand, Ya Meng, Bruce T. Seet, Victoria A. Landolfi, David Greenberg, Rosalind C. Hollingsworth · 2019 · Expert Review of Vaccines
Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage
Shahzma Merani, George A. Kuchel, Alison Kleppinger, Janet E. McElhaney · 2017 · Experimental Gerontology
Immunogenicity of Quadrivalent Influenza Vaccine for Patients with Inflammatory Bowel Disease Undergoing Immunosuppressive Therapy
Shimpei Shirai, Megumi Hara, Yasuhisa Sakata, Nanae Tsuruoka, Koji Yamamoto, Ryo Shimoda, Yasuyuki Gomi, Hironori Yoshii, Kazuma Fujimoto, Ryuichi Iwakiri · 2018 · Inflammatory Bowel Diseases
Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond
Birgit Weinberger · 2021 · Immunity & Ageing
Influenza: Can we cope better with the unpredictable?
Gaël Dos Santos, Elisabeth Neumeier, Rafik Bekkat-Berkani · 2015 · Human Vaccines & Immunotherapeutics
T follicular helper cell development and functionality in immune ageing
Claire E. Gustafson, Cornelia M. Weyand, Jörg J. Goronzy · 2018 · Clinical Science
Hybrid clinical trials to generate real-world evidence: design considerations from a sponsor's perspective
Ming Zhu, Saranya Sridhar, Rosalind C. Hollingsworth, Ayman Chit, Tammy Kimball, Kerry Murmello, Michael Greenberg, Sanjay Gurunathan, Josh Chen · 2019 · Contemporary Clinical Trials
Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2017: the Influenza Complications Alert Network (FluCAN)
Allen C Cheng, Mark Holmes, Dominic E. Dwyer, Sanjaya Senenayake, Louise Cooley, Louis B. Irving, Graham Simpson, Tony M. Korman, Kristine K. Macartney, N Deborah Friedman et al. · 2019 · Communicable Diseases Intelligence
Importance and value of adjuvanted influenza vaccine in the care of older adults from a European perspective – A systematic review of recently published literature on real-world data
Barbara Christine Gärtner, Thomas Weinke, K. Wahle, Anja Kwetkat, Dietmar Beier, K.J. Schmidt, Tino F. Schwarz · 2022 · Vaccine
Protection against influenza hospitalizations from enhanced influenza vaccines among older adults: A systematic review and network meta‐analysis
Jill M. Ferdinands, Lenee Blanton, Elif Alyanak, Jessie R. Chung, L. Trujillo, Joanna M. Taliano, Rebecca L. Morgan, Alicia M. Fry, Lisa A. Grohskopf · 2024 · Journal of the American Geriatrics Society
High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection against Tuberculosis
Rolf Billeskov, Thomas Lindenstrøm, Joshua S. Woodworth, Cristina Vilaplana, Père-Joan Cardona, Joseph P. Cassidy, Rasmus J. Mortensen, Else Marie Agger, Peter Lawætz Andersen · 2018 · Frontiers in Immunology
The Future of Influenza Vaccines: A Historical and Clinical Perspective
Nicole M. Bouvier · 2018 · Vaccines
Alternative strategies of posttransplant influenza vaccination in adult solid organ transplant recipients
Zaid Haddadin, Karen Krueger, Lora D. Thomas, Edgar Turner Overton, Michael G. Ison, Natasha Halasa · 2020 · American Journal of Transplantation
Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019–2020
Mark W. Tenforde, H. Keipp Talbot, Christopher H. Trabue, Manjusha Gaglani, Tresa McNeal, Arnold S. Monto, Emily Toth Martin, Richard Kent Zimmerman, Fernanda P. Silveira, Donald B. Middleton et al. · 2020 · The Journal of Infectious Diseases
Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States
William L. Herring, Yuanhui Zhang, Vivek Shinde, Jeffrey J. Stoddard, Sandra E. Talbird, Brian Roy Rosen · 2021 · Vaccine
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine
Benjamin John Cowling, George N. Okoli · 2024 · Drugs
Feasibility of a cluster-randomized influenza vaccination trial in U.S. nursing homes: Lessons learned
Stefan Gravenstein, H. Edward Davidson, Lisa Han, Jessica A. Ogarek, Roshani Dahal, Pedro L. Gozalo, Monica Taljaard, Vincent Mor · 2017 · Human Vaccines & Immunotherapeutics
Antibody-Dependent Cellular Cytotoxicity Responses to Seasonal Influenza Vaccination in Older Adults
Hillary A. Vanderven, Sinthujan Jegaskanda, Bruce D. Wines, Philip Mark Hogarth, Sarina Carmuglia, Steven P. Rockman, Amy W. Chung, Stephen John Kent · 2017 · The Journal of Infectious Diseases
Cluster-randomized Trial of Adjuvanted Versus Nonadjuvanted Trivalent Influenza Vaccine in 823 US Nursing Homes
Kevin W. McConeghy, H. Edward Davidson, David H. Canaday, Lisa Han, Elie Saade, Vince Mor, Stefan Gravenstein · 2020 · Clinical Infectious Diseases
A re-randomisation design for clinical trials
Brennan C Kahan, Andrew Benjamin Forbes, Caroline J Doré, Tim Peter Morris · 2015 · BMC Medical Research Methodology
Next-Generation Influenza Vaccines
Masaru Kanekiyo, Barney S. Graham · 2020 · Cold Spring Harbor Perspectives in Medicine
Cost‐Effectiveness and Public Health Effect of Influenza Vaccine Strategies for U.S. Elderly Adults
Jonathan M. Raviotta, Kenneth J. Smith, Jay V. DePasse, Shawn T. Brown, Eunha Shim, Mary Patricia Nowalk, Richard Kent Zimmerman · 2016 · Journal of the American Geriatrics Society
Cytomegalovirus Seropositivity Predicts a Decline in the T Cell But Not the Antibody Response to Influenza in Vaccinated Older Adults Independent of Type 2 Diabetes Status
Kamran Haq, Tamàs Fülöp, Gale Tedder, Beth Gentleman, Hugo Garneau, Graydon S. Meneilly, Alison Kleppinger, Graham Pawelec, Janet E. McElhaney · 2016 · The Journals of Gerontology Series A
Review of Influenza Virus Vaccines: The Qualitative Nature of Immune Responses to Infection and Vaccination Is a Critical Consideration
Lily Chan, Kasra Alizadeh, Kimia Alizadeh, Fatemeh Fazel, Julia E. Kakish, Negar Karimi, Jason P. Knapp, Yeganeh Mehrani, Jessica A. Minott, Solmaz Morovati et al. · 2021 · Vaccines
Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial
Stéphanie Pépin, Jean‐François Nicolas, Henryk Szymański, Isabel Leroux‐Roels, Thomas Schaum, Marc J. M. Bonten, Giancarlo Icardi, Anju Shrestha, Cynthia Tabar, The QHD00011 study team · 2021 · Human Vaccines & Immunotherapeutics
Influenza vaccination: a one-shot deal to reduce cardiovascular events
Orly Vardeny, Scott David Solomon · 2016 · European Heart Journal
National trends in prescription drug expenditures and projections for 2015
Glen T. Schumock, Edward C. Li, Katie J. Suda, Michelle Dusing Wiest, JoAnn Stubbings, Linda M. Matusiak, Robert J. Hunkler, Lee C. Vermeulen · 2015 · American Journal of Health-System Pharmacy